Insulin, diabetes

Novolog Engineered short-acting insulin Diabetes mellitus 11... [Pg.111]

Becker RHA, Sha S, Frick AD, Fountaine RJ (2006) The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care 29 277-282. [Pg.155]

Sources. 1. Walsh J. Insulin—Diabetes Mall, http //www.diabetesnet.com/diabetes treatments/insulinjnhaled.php [accessed August 21,2007]. (2) Exubera Official Site, http // www.exubera.com/content/con index.jsp printFriendl=true [accessed November 13,2007). [Pg.123]

Insulin Diabetes mellitus Porcine/bovine pancreatic tissue... [Pg.13]

R. Quintana, and D.A. Shapiro, Insulin administration via the Aero Dose (TM) inhaler Comparison to subcutaneously injected insulin. Diabetes, 2000. 49 ... [Pg.379]

Fink and Nemeroff (32) postulated the existence of a neuropeptide, antidepressin, that is released by diencephalic stimulation and enhances hypothalamic, and perhaps limbic, function. Repeated ECT-induced seizures and the resultant increased levels of acetylcholine may promote the production of this putative peptide. In support of their theory, these authors discuss several lines of evidence. Using the analogy of the insulin-diabetes model, they note that ... [Pg.166]

Diabetes mellitus is a heterogeneous group of syndromes characterized by an elevation of fasting blood glucose that is caused by a relative or absolute deficiency in insulin. Diabetes is the leading cause of adult blindness and amputation and a major cause of renal failure, heart attack, and stroke. The disease can be classified into two groups, type 1 and type 2. [Pg.497]

In an open study of 107 patients with type 2 diabetes using the AERx insulin diabetes management system (n = 54) or subcutaneous insulin (n — 53), the number of people with insulin antibodies increased from 6% to 35% in those who used the AERx insulin diabetes management system (271). The number of patients with antibodies remained stable at about 10% in those who used subcutaneous insulin. There were no obvious clinical consequences. Similar results were found in a study of patients with type 1 diabetes 29% of those who used inhaled insulin compared with 3% of those who used subcutaneous insulin (272). [Pg.410]

George E, Bedford C, Peacey SR, Hardisty CA, Heller SR. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM no effect of dose for dose transfer between human and porcine insulins. Diabet Med 1997 14(6) 442—8. [Pg.415]

Tawata M, Ikeda M, Kodama Y, Aida K, Onaya T. A type 2 diabetic patient with liver dysfunction due to human insulin. Diabetes Res Clin Pract 2000 49(1) 17-21. [Pg.416]

Sola-Gazagnes A, Pecquet C, Radermecker R, Pietri L, Elgrably F, Slama G, Selam J-L. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Diabetes Care 2003 26 2961-2. [Pg.417]

Charles MA. Autoimmunity and intraperitoneal insulin. Diabetes Care 1998 21 2043-4. [Pg.417]

Naf S, Esmatjes E, Recasens M, Valero A, Halperin I, Levy I, Gomis R. Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care 2002 25(3) 634-5. [Pg.417]

Pratt EJ, Miles P, Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diabet Med 2001 18(6) 515-6. [Pg.417]

Heinemann L, Traut T, Heise T. Time-action profile of inhaled insulin. Diabet Med 1997 14(l) 63-72. [Pg.418]

Renard E, Souche C, Jacques-Apostol D, Lauton D, Gibert-Boulet F, Costalat G, Bringer J, Jaffiol C. Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care 1999 22(8) 1371-2. [Pg.420]

Himmelmann A, Jendle J, Mellen A, Petersen AH, Dahl UL, Wollmer P. The impact of smoking on inhaled insulin. Diabetes Care 2003 26(3) 677-82. [Pg.420]

Kim D, An B, Reinhardt RR. Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects. Diabetes Care 2003 26(3) 764-9. [Pg.421]

Hermansen K, Ronnemaa T, Petersen AH, Bellaire S, Adamson U. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system. Diabetes Care 2004 27 162-7. [Pg.421]

An B, Reinhardt RR. Effects of different duration of breath holding after inhalation of insulin using the AERx insulin diabetes management system. Clin Ther 2003 25 2233 14. [Pg.421]

Gershonov E, Shechter Y, Fridkin M. New concept for long-acting insulin spontaneous conversion of an inactive modified insulin to the active hormone in circulation 9-fluorenylmethoxycarbonyl derivative of insulin. Diabetes 1999 48(7) 1437-42. [Pg.423]

Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 2001 24(4) 631-6. [Pg.427]

Herz M, Arora V, Sun B, Ferguson SC, Bolli GB, Frier BM. Basal-bolus insulin therapy in Type 1 diabetes comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin. Diabet Med 2002 19(ll) 917-23. [Pg.432]

Joseph SE, Korzon-Burakowska A, Woodworth JR, Evans M, Hopkins D, Janes JM, Amiel SA. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin. Diabetes Care 1998 21(12) 2098—102. [Pg.432]

Ferguson SC, Strachan MW, Janes JM, Frier BM. Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia a comparative study of insulin lispro and regular human insulin. Diabetes Metab Res Rev 2001 17(4) 285-91. [Pg.432]

A. Ahmann. Lessons on developing a better basal insulin. Diabetes Technol. Then 6 596-600, 2004. [Pg.39]

Eli Lilly Humulin (humin insulin) Diabetes Expired Expired... [Pg.190]

Insulin Diabetes Human (416 type-1 diabetic patients) Inhalation (Exubera ) Inhaled insulin effective, well-tolerated and well-accepted [60]... [Pg.210]

Insulin Diabetes Human (18 type-I diabetic patients) Inhalation (AERx ) Pharmacodynamic system efficiency 12.7%. Dose-response relationship close to linear [64]... [Pg.210]

Insulin Diabetes Human (Healthy volunteers type-II diabetic patients Inhalation (Technosphere) Relative bioavailability 50% for the first 3 h and 30% for the entire 6-h period [121]... [Pg.210]

Insulin Diabetes Human (26 type-II diabetic patients) Inhalation 3-month treatment significantly improved glycemic control compared with baseline [122]... [Pg.210]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...